Using Ustekinumab to Treat Crohn's Disease-Related Orofacial Granulomatosis: Two Birds, One Stone

Inflamm Bowel Dis. 2020 Jul 17;26(8):e79-e80. doi: 10.1093/ibd/izaa123.

Authors

Robert Gilmore¹, Christopher F D Li Wai Suen^{1

2}, Tim Elliott¹, Peter De Cruz^{1

2}, Ashish Srinivasan^{1

3}

Affiliations

¹ Department of Gastroenterology, Austin Health, Melbourne, Australia.
² Department of Medicine, Austin Academic Centre, University of Melbourne, Melbourne, Australia.
³ Monash University, Department of Medicine, Melbourne, Australia.

PMID: 32448910
DOI: 10.1093/ibd/izaa123

No abstract available

Keywords: Crohn’s disease; orofacial granulomatosis; ustekinumab.

Publication types

Case Reports
Letter
Research Support, Non-U.S. Gov't

MeSH terms

Adult
Crohn Disease / complications
Crohn Disease / drug therapy*
Granulomatosis, Orofacial / drug therapy*
Granulomatosis, Orofacial / etiology
Humans
Male
Medical Illustration
Ustekinumab / therapeutic use*

Substances

Ustekinumab